Yes, different headlines, but exactly the same worded content in announcement/article.
"Dr. Samuel Lundin, CEO of Biotome said: “We believe the precision of antibody tests for infections can be improved dramatically. Our partnership with Brainchip is an important step for our development of point-of-care tests that are based on patented high-precision immunological markers."
Biotome Partnership, page-60
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.0¢ |
Change
0.035(13.7%) |
Mkt cap ! $572.0M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 29.0¢ | 26.0¢ | $10.11M | 36.62M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 22403 | 28.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 628072 | 21 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| BRN (ASX) Chart |